Market Reports

BioInformant's Market Reports emphasizes rapidly changing trends within the life science industry and emphasize profitable opportunities that companies in this sector can pursue. BioInformant uses its proprietary search technologies to estimate market size, market share, market growth, and market patterns (cyclicity within a calendar year). To supplement the “hard” data collected by internet algorithms designed for each research project, BioInformant’s Team of Market Analysts add qualitative analysis to each report, providing a high-tech, high-touch result.

We currently have reports available for the following business areas:

TOPIC	DESCRIPTION	PRICE
Poly(ADP-ribose) polymerase (PARP) Research Products	Currently, a great deal of research being done on PARP, because its activity is linked to many diseases, including cancer, ischemia, diabetes, arthritis, inflammatory bowel disease, and septic shock. Of great therapeutical interest are PARP-1 inhibitors, as they exert a duel effect of inhibiting cell death and reducing inflammation. PARP inhibitors are effective as radiation-sensitizing agents and appear promising in the treatment of conditions involving oxidative stress. Quantification of PARP activity and identification of abnormal patterns of PARP degradation by proteases might also aid in diagnosis of conditions. Provision of PARP products to researchers worldwide represents a lucrative financial opportunity, which is explored in detail within this report.	Only $3,495
Stem Cell Research Products	Currently, the federal government is an important, although not dominant, source of funding for stem cell research. States are spending almost as much as the federal government on adult stem cell research and are spending more than the federal government on human embryonic stem cell (hESC) research. Private sources also contribute a huge about of funding, with analysis of recent large gifts summing to over $1.7 billion. This report explores the size of the stem cell research products market, its growth rate, recent scientific development and emerging product opportunities.	Only $3,495
Tissue Engineering & Cell Transplantation	Due to the large number of potential patients targeted by tissue engineering and organ regeneration products, and the excessive medical costs associated with existing treatments for these patients, the total market for tissue engineering and organ regeneration products is vast, with several applications representing multi-billion-dollar opportunities. In the U.S., the total potential market for all applications of tissue engineering and organ regeneration is approximately $90 billion. While the current market is still in its very early stages of development, advances in our understanding of genetic and cellular mechanisms are expected to significantly increase this market during the coming decade. TD>	Only $3,995
Worldwide Market for Synthetic Blood Products	This thorough evaluation of synthetic blood products provides an analysis of all key market opportunities, including products on the market and in development, as well as unmet needs. The report also provides discussions of the synthetic blood product trends, including regulatory, business, and clinical challenges. Profiles of 25 dominant companies in the industry are included.	Only $3,995

ABOUT BIOINFORMANT'S MARKET RESEARCH REPORTS:

We maintain the highest quality standards in generating our market research reports.

Reports are provided by email, in PDF format, within 24 hours of payment. We strive to make every client a repeat client, so all lists are backed by a 90-Day Money Back Guarantee. Try them today! What do you have to lose?

Questions? Use the Contact Us form to get them answered!

We look forward to assisting you in making profitable business decisions.

www.BIOINFORMANT.com         info@bioinformant.com       (Fax) 614-352-2369

Copyright © 2007 BioInformant. All rights reserved.

Home | Company | Resources | Products | Contact Us | Sitemap